Literature DB >> 33533390

Microfluidic model with air-walls reveals fibroblasts and keratinocytes modulate melanoma cell phenotype, migration, and metabolism.

Jose M Ayuso1, Shreyans Sadangi, Marcos Lares, Shujah Rehman, Mouhita Humayun, Kathryn M Denecke, Melissa C Skala, David J Beebe, Vijayasaradhi Setaluri.   

Abstract

Melanoma evolution is a complex process. The role epidermal keratinocytes and dermal fibroblasts play in this process and the mechanisms involved in tumor-stroma interactions remain poorly understood. Here, we used a microfluidic platform to evaluate the cross-talk between human primary melanoma cells, keratinocytes and dermal fibroblasts. The microfluidic device included multiple circular chambers separated by a series of narrow connection channels. The microdevice design allowed us to develop a new cell patterning method based on air-walls, removing the need for hydrogel barriers, porous membranes, or external equipment. Using this method, we co-cultured melanoma cells in the presence of keratinocytes and/or dermal fibroblasts. The results demonstrated that the presence of dermal fibroblasts and keratinocytes led to changes in melanoma cell morphology and growth pattern. Molecular analysis revealed changes in the chemokine secretion pattern, identifying multiple secreted factors involved in tumor progression. Finally, optical metabolic imaging showed that melanoma cells, fibroblasts, and keratinocytes exhibited different metabolic features. Additionally, the presence of stromal cells led to a metabolic shift in melanoma cells, highlighting the role the skin microenvironment on melanoma evolution.

Entities:  

Mesh:

Year:  2021        PMID: 33533390      PMCID: PMC7990711          DOI: 10.1039/d0lc00988a

Source DB:  PubMed          Journal:  Lab Chip        ISSN: 1473-0189            Impact factor:   6.799


  39 in total

1.  Modeling the Blood-Brain Barrier in a 3D triple co-culture microfluidic system.

Authors:  G Adriani; D Ma; A Pavesi; E L K Goh; R D Kamm
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015

2.  Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro.

Authors:  Kambez H Benam; Remi Villenave; Carolina Lucchesi; Antonio Varone; Cedric Hubeau; Hyun-Hee Lee; Stephen E Alves; Michael Salmon; Thomas C Ferrante; James C Weaver; Anthony Bahinski; Geraldine A Hamilton; Donald E Ingber
Journal:  Nat Methods       Date:  2015-12-21       Impact factor: 28.547

3.  Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids.

Authors:  Venktesh S Shirure; Ye Bi; Matthew B Curtis; Andrew Lezia; Madeleine M Goedegebuure; S Peter Goedegebuure; Rebecca Aft; Ryan C Fields; Steven C George
Journal:  Lab Chip       Date:  2018-11-05       Impact factor: 6.799

4.  Fibroblasts contribute to melanoma tumor growth and drug resistance.

Authors:  Edward H Flach; Vito W Rebecca; Meenhard Herlyn; Keiran S M Smalley; Alexander R A Anderson
Journal:  Mol Pharm       Date:  2011-11-08       Impact factor: 4.939

5.  The importance of being a lumen.

Authors:  Lauren L Bischel; Kyung E Sung; José A Jiménez-Torres; Brianah Mader; Patricia J Keely; David J Beebe
Journal:  FASEB J       Date:  2014-07-30       Impact factor: 5.191

6.  Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation.

Authors:  Jessie S Jeon; Simone Bersini; Mara Gilardi; Gabriele Dubini; Joseph L Charest; Matteo Moretti; Roger D Kamm
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-18       Impact factor: 11.205

7.  Interleukin-8 and de novo mammalian angiogenesis.

Authors:  K Norrby
Journal:  Cell Prolif       Date:  1996-06       Impact factor: 6.831

8.  Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.

Authors:  Olga Kholmanskikh; Nicolas van Baren; Francis Brasseur; Sabrina Ottaviani; Julie Vanacker; Nathalie Arts; Pierre van der Bruggen; Pierre Coulie; Etienne De Plaen
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

9.  Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients.

Authors:  Jose M Ayuso; Maria Virumbrales-Munoz; Patrick H McMinn; Shujah Rehman; Ismael Gomez; Mohammad R Karim; Regan Trusttchel; Kari B Wisinski; David J Beebe; Melissa C Skala
Journal:  Lab Chip       Date:  2019-10-09       Impact factor: 6.799

10.  Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis.

Authors:  S K Srivastava; A Bhardwaj; S Arora; N Tyagi; A P Singh; J E Carter; J G Scammell; Ø Fodstad; S Singh
Journal:  Br J Cancer       Date:  2015-05-05       Impact factor: 7.640

View more
  5 in total

Review 1.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

2.  Advances in 3D Vascularized Tumor-on-a-Chip Technology.

Authors:  Sangmin Jung; Hyeonsu Jo; Sujin Hyung; Noo Li Jeon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Role of the Skin Microenvironment in Melanomagenesis: Epidermal Keratinocytes and Dermal Fibroblasts Promote BRAF Oncogene-Induced Senescence Escape in Melanocytes.

Authors:  Shreyans Sadangi; Katarina Milosavljevic; Edgardo Castro-Perez; Marcos Lares; Mithalesh Singh; Sarah Altameemi; David J Beebe; Jose M Ayuso; Vijayasaradhi Setaluri
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

Review 4.  3D Bioprinting: An Enabling Technology to Understand Melanoma.

Authors:  Samantha Fernandes; Cian Vyas; Peggy Lim; Rúben F Pereira; Amaya Virós; Paulo Bártolo
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

5.  Melanoma stimulates the proteolytic activity of HaCaT keratinocytes.

Authors:  Justyna Mazurkiewicz; Aleksandra Simiczyjew; Ewelina Dratkiewicz; Magdalena Kot; Katarzyna Pietraszek-Gremplewicz; Dominika Wilk; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.